This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Title of project or programme
Wellcome Trust/MRC Strategic Award: Mechanisms of neurotoxicity of amyloid aggregates
Principal Investigators of project/programme grant
| Title | Forname | Surname | Institution | Country |
| Professor | Peter | St George Hyslop | University of Cambridge | UK |
Address of institution of lead PI
| Institution | Cambridge Institute for Medical Research |
| Street Address | Wellcome Trust/MRC Building, Addenbrooke’s Hospital, Hills Road |
| City | Cambridge |
| Postcode | CV2 0XY |
Country
- United Kingdom
Source of funding information
Medical Research Council
Total sum awarded (Euro)
7151557.53
Start date of award
01-01-2010
Total duration of award in months
60
The project/programme is most relevant to
- Alzheimer’s disease and other dementias
Keywords
Research abstract in English
Some of the most important but unresolved questions about the pathobiology of Alzheimer’s disease (AD) are: What are the neurotoxic species of Abeta? How do they injure neurons? How do they induce aggregation of intracellular proteins like tau, alpha-synuclein, and TDP-43? Why are the normal mechanisms for removal of these intracellular aggregation-prone proteins overwhelmed in AD? Answers to such questions will provide both insight into the early stages of disease pathogenesis, and starting points for the discovery of novel diagnostics and therapeutics.
We hypothesize that the neurotoxicity of Abeta arises from heterogeneous mixtures of soluble Abeta aggregates, which may have differing toxicities, but which activate complex, interlinked downstream pathways. To deconvolute this complexity we will apply an integrated suite of tools from physics, chemistry, engineering, systems biology and neurobiology to: 1) Investigate Abeta aggregation and its consequences in living cells and animals; 2) Identify its molecular targets; 3) Discover the downstream metabolic and signalling pathways activated by Abeta; 4) Identify the molecular mechanisms by which Abeta induces misprocessing of tau; and 5) Identify the regulators of autophagy (which is an important physiological mechanisms for removal of tau) and determine why autophagy is down-regulated in AD)
Lay Summary
Wellcome Trust/MRC Strategic Award: Mechanisms of neurotoxicity of amyloid aggregates
Investments > €500k
United Kingdom
Alzheimer’s disease & other dementias
2011